Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation

被引:251
作者
Wang, SY
Garcia, AJ
Wu, M
Lawson, DA
Witte, ON
Wu, H
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
关键词
animal model; prostate cancer; Pten conditional knockout; stem cell proliferation and differentiation; tumor progression;
D O I
10.1073/pnas.0510652103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a potent tumor suppressor gene frequently mutated in human prostate cancers. Deletion of Pten in a murine model of prostate cancer recapitulates the disease progression seen in humans. Using defined cell lineage markers, we demonstrate that PTEN negatively regulates p63-positive prostatic basal cell proliferation without blocking differentiation. Concomitant with basal cell proliferation is the expansion of a prostate stem/progenitor-like subpopulation as evidenced by the progressive increase of stem cell antigen-1 (Sca-1)- and BCL-2-positive cells. This observation provides strong evidence that basal cell proliferation can be an initiating event for precancerous lesions. Sca-1(+) and BCL-2(+) progenitors may serve as cancer-initiating cells in this model.
引用
收藏
页码:1480 / 1485
页数:6
相关论文
共 38 条
[1]   Therapeutic implications of cancer stem cells [J].
Al-Hajj, M ;
Becker, MW ;
Wichal, M ;
Weissman, I ;
Clarke, MF .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :43-47
[2]   Stem cell genes in androgen-independent prostate cancer [J].
Bui, M ;
Reiter, RE .
CANCER AND METASTASIS REVIEWS, 1998, 17 (04) :391-399
[3]   Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue [J].
Burger, PE ;
Xiong, XH ;
Coetzee, S ;
Salm, SN ;
Moscatelli, D ;
Goto, K ;
Wilson, EL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (20) :7180-7185
[4]   POSSIBLE INFLUENCE OF TEMPORAL FACTORS IN ANDROGENIC RESPONSIVENESS OF UROGENITAL TISSUE RECOMBINANTS FROM WILD-TYPE AND ANDROGEN-INSENSITIVE (TFM) MICE [J].
CUNHA, GR ;
LUNG, B .
JOURNAL OF EXPERIMENTAL ZOOLOGY, 1978, 205 (02) :181-193
[5]   Chronic myeloid leukemia: Proving ground for cancer stem cells [J].
Daley, GQ .
CELL, 2004, 119 (03) :314-316
[6]   Stem cell features of benign and malignant prostate epithelial cells [J].
De Marzo, AM ;
Nelson, WG ;
Meeker, AK ;
Coffey, DS .
JOURNAL OF UROLOGY, 1998, 160 (06) :2381-2392
[7]   Prostate stem cell compartments -: Expression of the cell cycle inhibitor p27Kip1 in, normal, hyperplastic, and neoplastic cells [J].
De Marzo, AM ;
Meeker, AK ;
Epstein, JI ;
Coffey, DS .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :911-919
[8]  
Dubey P, 2001, CANCER RES, V61, P3256
[9]   RESPONSE OF GLANDULAR VERSUS BASAL RAT VENTRAL PROSTATIC EPITHELIAL-CELLS TO ANDROGEN WITHDRAWAL AND REPLACEMENT [J].
ENGLISH, HF ;
SANTEN, RJ ;
ISAACS, JT .
PROSTATE, 1987, 11 (03) :229-242
[10]   The development of androgen-independent prostate cancer [J].
Feldman, BJ ;
Feldman, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :34-45